SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

14 Jun 2023 07:00

RNS Number : 6184C
Victrex PLC
14 June 2023
 
 

14 June 2023

Victrex plc - Trading update

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. Today's trading update covers the period ending 31 May 2023.

Year-to-date (YTD) Group volume & revenue

At the Group's interim results we signalled that, in line with the wider Chemical sector, ongoing macro-economic weakness and industrial customer destocking were impacting performance in several end markets. During the first half, Group volumes declined by 14%.

Whilst the Group remains ready to benefit from a macro-economic recovery, latest indicators suggest these current headwinds will now continue over the summer and at least until the end of FY 2023 in September.

Despite good progress in Medical, ongoing industrial headwinds mean YTD Group volumes are now tracking in excess of 20% down, compared to the record prior year. YTD Group revenue is tracking down by a mid-single digit percentage rate. If current run-rates continue, full year revenue would be down between 6%-10%.

For Q3 as a whole, we anticipate volumes will be approximately 800 tonnes (Q3 2022: 1,323 tonnes).

Outlook

In our Outlook at the interim results stage, we signalled that delivering full-year adjusted (pre-exceptional) profit before tax (PBT) in line with expectations assumed a step up in demand during the latter part of the second half, driven by macro-economic conditions.

Whilst we are seeing progress on gross margin, driven by pricing, sales mix, currency and easing energy costs, Group adjusted PBT to 31 May 2023 was approximately £53m. With no step up in demand going into the final quarter currently visible, and the resulting lower industrial revenue expectations, our full year adjusted PBT is now expected to be between £80m-£85m.  

Victrex will report its Q3 Interim Management Statement on Thursday 6 July 2023.

 

Analyst & investor conference call:

A conference call with management will take place this morning, 14 June 2023, at 08.00am BST. The call can be accessed via the following link:

 

https://services.choruscall.za.com/DiamondPassRegistration/register?confirmationNumber=2616372&linkSecurityString=6aee7987c

 

Inside information:

This announcement contains inside information. The person responsible for making this announcement is Jane Brisley, General Counsel & Company Secretary.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG +44 (0) 7809 595831

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

Ian Melling, Chief Financial Officer +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUAAQUPWPGW
Date   Source Headline
16th Dec 20154:37 pmRNSDirector/PDMR Shareholding
15th Dec 201512:03 pmRNSDirector/PDMR Shareholding
9th Dec 20152:34 pmRNSDirector/PDMR Shareholding
8th Dec 20154:43 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSFinal Results
4th Dec 20154:07 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSHolding(s) in Company
1st Dec 20152:54 pmRNSBlocklisting Interim Review
30th Nov 20153:39 pmRNSTotal Voting Rights
20th Nov 20154:04 pmRNSHolding(s) in Company
17th Nov 20154:08 pmRNSDirector/PDMR Shareholding
30th Oct 201510:32 amRNSTotal Voting Rights
19th Oct 20153:13 pmRNSDirector/PDMR Shareholding
8th Oct 20157:00 amRNSTrading Statement
30th Sep 20151:56 pmRNSTotal Voting Rights
29th Sep 20154:19 pmRNSDirectorate Change
28th Sep 20154:28 pmRNSDirector/PDMR Shareholding
24th Sep 201511:50 amRNSDirector/PDMR Shareholding
21st Sep 201511:42 amRNSHolding(s) in Company
17th Sep 201511:23 amRNSDirector/PDMR Shareholding
28th Aug 201512:06 pmRNSTotal Voting Rights
26th Aug 20154:24 pmRNSHolding(s) in Company
18th Aug 20152:12 pmRNSDirector/PDMR Shareholding
31st Jul 20154:09 pmRNSTotal Voting Rights
31st Jul 20152:24 pmRNSHolding(s) in Company
31st Jul 201512:08 pmRNSDirectorate Change
21st Jul 20157:00 amRNSInterim Management Statement
20th Jul 20159:58 amRNSDirector/PDMR Shareholding
30th Jun 20153:38 pmRNSTotal Voting Rights
26th Jun 201511:07 amRNSDirector Declaration
17th Jun 20154:06 pmRNSDirector/PDMR Shareholding
1st Jun 20153:52 pmRNSBlocklisting Interim Review
29th May 201510:00 amRNSTotal Voting Rights
26th May 20154:39 pmRNSDirector/PDMR Shareholding
19th May 20153:58 pmRNSDirector/PDMR Shareholding
19th May 20159:52 amRNSVictrex first half pretax profit jumps 10%
19th May 20157:00 amRNSHalf Yearly Report
11th May 20154:31 pmRNSHolding(s) in Company
6th May 20154:34 pmRNSHolding(s) in Company
30th Apr 20152:30 pmRNSTotal Voting Rights
28th Apr 20154:34 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSCapital Markets Day
20th Apr 20153:23 pmRNSDirector/PDMR Shareholding
9th Apr 20157:00 amRNSTrading Statement
31st Mar 20153:25 pmRNSTotal Voting Rights
26th Mar 20153:20 pmRNSDirectorate Change
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 20154:32 pmRNSHolding(s) in Company
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.